POCI vs PRPO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
POCI exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. While the company shows impressive top-line revenue growth of 62.80%, this growth is not translating into profitability, as evidenced by a -28.33% profit margin and a catastrophic -73.56% ROE. Liquidity is tight with a Quick Ratio of 0.58, and the company has failed to beat earnings estimates in the last four quarters. The recent short-term price rally appears decoupled from the underlying financial deterioration.
PRPO exhibits a severe disconnect between its recent price appreciation (+381% 1Y) and its fundamental health, highlighted by a critical Piotroski F-Score of 2/9. While the company shows promising top-line growth (22.9% YoY) and a positive operating margin (8.09%), it remains net-unprofitable with a prohibitively high Forward P/E of 72.56. The technical trend has collapsed to 10/100, suggesting the recent rally was speculative and is now reversing. Overall, the combination of weak deterministic health scores and extreme valuation makes the current price unsustainable.
Compare Another Pair
Related Comparisons
POCI vs PRPO: Head-to-Head Comparison
This page compares Precision Optics Corporation, Inc. (POCI) and Precipio, Inc. (PRPO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.